louisiana semaglutide nausea class action Ozempic Lawsuit [July 2026 Update] Long Island patients claim vision

Semaglutide Semaglutide is a GLP-1 receptor agonist that is dosed once a week subcutaneously based on its extended half-life

Common side effects (occurring in 5% of patients) include nausea, diarrhea, vomiting, constipation, and abdominal pain

usually mild-to-moderate and easing over time [1]

Its unique mechanism targets GLP-1 alongside glucagon receptor pathways, and studies examine its metabolic effects on energy expenditure, energy balance, glucose regulation, and gastric emptying

But progesterone's role in this combination is not merely protective

Wang R, Yu Q, Wang X, Li B, Ciotkowska A, Rutz B, Wang Y, Stief CG, Hennenberg M (2020) Rac1 silencing, NSC23766 and EHT1864 reduce growth and actin organization of bladder smooth muscle cells